Rebeca Manso

Learn More
PURPOSE SET is an endogenous PP2A inhibitor that might represent a novel molecular target for antitumor therapy. The aim of this study was to evaluate the molecular effects of SET deregulation and(More)
Regular physical activity is recognized as a non-pharmacological treatment of genetic obesity and type-II diabetes, and based on the “anti-inflammatory” effects of exercise, it has been also proposed(More)